Sex differences in heart failure with preserved ejection fraction: From traditional risk factors to sex-specific risk factors.
Sex differences in heart failure with preserved ejection fraction: From traditional risk factors to sex-specific risk factors.
复制标题
DOI:
10.1177/17455057221140209
复制
发表时间:
2022-01
期刊:
影响因子:
2.4
通讯作者:
Lau, Emily
中科院分区:
文献类型:
--
作者:
Kaur, Gurleen;Lau, Emily
Heart failure with preserved ejection fraction has a higher prevalence in women versus men. There are several proposed mechanisms to explain this sex discrepancy including differences in cardiovascular adaptation to comorbidities and potential underlying etiologic mechanisms. In this review, we summarize sex differences in traditional risk factors, such as obesity, diabetes, hypertension, and coronary artery disease, which contribute to the development of heart failure with preserved ejection fraction in women. Furthermore, we explore female-specific risk factors, such as sex hormones, adverse pregnancy outcomes, and other reproductive factors, which may explain the predominance of heart failure with preserved ejection fraction in women. Beyond sex differences in risk factors, there are also significant sex differences in outcomes with women reporting lower quality of life but overall better survival versus men. Finally, while treatment options for patients with heart failure with preserved ejection fraction are still limited, sex differences have also been reported for the available therapies, with suggestion of preferential benefit of specific heart failure with preserved ejection fraction therapies in women. Further work is required to better understand sex differences in heart failure with preserved ejection fraction, including deeper understanding of pathophysiological mechanisms, derivation of more accurate risk stratification models, and increased representation of women in clinical trials.
登录
查看更多内容
影响因子:
13.8
作者:
Hansen AL;Søndergaard MM;Hlatky MA;Vittinghof E;Nah G;Stefanick ML;Manson JE;Farland LV;Wells GL;Mongraw-Chaffin M;Gunderson EP;Van Horn L;Wild RA;Liu B;Shadyab AH;Allison MA;Liu S;Eaton CB;Honigberg MC;Parikh NI
通讯作者:
Parikh NI
影响因子:
3.5
作者:
Faxen, Ulrika Ljung;Hage, Camilla;Lund, Lars H.
通讯作者:
Lund, Lars H.
DOI:
10.1161/hhf.0b013e318291329a
发表时间:
2013-05
期刊:
Circulation. Heart failure
影响因子:
--
作者:
Heidenreich PA;Albert NM;Allen LA;Bluemke DA;Butler J;Fonarow GC;Ikonomidis JS;Khavjou O;Konstam MA;Maddox TM;Nichol G;Pham M;Piña IL;Trogdon JG;American Heart Association Advocacy Coordinating Committee;Council on Arteriosclerosis, Thrombosis and Vascular Biology;Council on Cardiovascular Radiology and Intervention;Council on Clinical Cardiology;Council on Epidemiology and Prevention;Stroke Council
通讯作者:
Stroke Council
影响因子:
7.1
作者:
Breetveld, N. M.;Ghossein-Doha, C.;Spaanderman, M. E. A.
通讯作者:
Spaanderman, M. E. A.
影响因子:
39.3
作者:
GARAVAGLIA, GE;MESSERLI, FH;OREN, S
通讯作者:
OREN, S